From neurons to the neuro-glio-vascular unit: Seizures and brain homeostasis in networks

• Published in: Revue neurologique Vol. 179; no. 4; pp. 308 - 315
• Main Authors: Cresto, N., Janvier, A., Marchi, N.
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.04.2023; Elsevier Masson
• Subjects: Astrocytes; Biomarkers; Blood-Brain Barrier - pathology; Blood–brain barrier; Brain - pathology; Epilepsy - diagnosis; Epilepsy - etiology; Epilepsy - pathology; Epileptogenic; Homeostasis; Humans; Immunity; Inflammation; Life Sciences; Microglia; Neuroinflammatory Diseases; Neurons - pathology; Neurons and Cognition; Pericytes; Seizure propagation; Seizures - diagnosis; Seizures - etiology; Astrocytes; Pericytes; Homeostasis; Biomarkers; Inflammation; Epileptogenic; Seizure propagation; Immunity; Blood–brain barrier; Microglia
• ISSN: 0035-3787
• DOI: 10.1016/j.neurol.2022.12.005

While seizures are undoubtedly neuronal events, an ensemble of auxiliary brain cells profoundly shapes synaptic transmission in health and disease conditions. Endothelial-astrocyte-pericyte assemblies at the blood–brain barrier (BBB) and neuroglia within the neuro-glio-vascular unit (NGVU) finely tune brain parenchymal homeostasis, safeguarding the ionic and molecular compositions of the interstitial fluid. BBB permeability with neuroinflammation and the resulting loss of brain homeostatic control are unifying mechanisms sustaining aberrant neuronal discharges, with temporal specificities linked to acute (head trauma, stroke, infections) and pre-existent (genetic) or chronic ( dysplasia, tumors, neurodegenerative disorders) pathological conditions. Within this research template, one hypothesis is that the topography of BBB damage and neuroinflammation could associate with symptoms, e.g., limbic structures for seizures or pre-frontal for psychiatric episodes. Another uncharted matter is whether seizure activity, without tissue lesions or sclerosis, is sufficient to promote stable cellular-level maladaptations in networks. Contingent to localization and duration, BBB damage and inflammation forecast pathological trajectories, and the concept of an epileptic NGVU could enable time-sensitive biomarkers to predict disease progression. The coherence between electrographic, imaging and molecular NGVU biomarkers could be established from the epileptogenic to the propagating zones. This paradigm shift could lead to new diagnostic and therapeutic modalities germane to specific epilepsies or when seizure activity represents a comorbidity.